First approval for hep C contender simeprevir, in Japan
This article was originally published in Scrip
It seems that Japan's Pharmaceuticals and Medical Devices Agency (PMDA) is taking concrete actions to back up its stated goal of being the first in the world to approve new products in the fields it regulates.
You may also be interested in...
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things.
Highlighting progress it has made over the past few years, Japan’s regulatory agency says it wants to raise even further the number of “Japan-first” approvals, as part of its stated mission to get safe and effective new drugs to patients more quickly.
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.